SEATTLE, Wash. – Patients who arrive unconscious with a head injury at Harborview Medical Center in Seattle may be given a drug being tested to prevent bleeding in the brain, even though they are unable to give their consent.
The hospital’s chief trauma doctor, Dr. Eileen Bulger, says the drug known as TXA is already approved to stop internal bleeding.
She’s leading the study to determine if giving the drug as early as possible helps with traumatic brain injury.
The hospital is currently doing community outreach.
Enrollment in the study won’t begin until it gets approval from a review panel at the University of Washington.
The Seattle Times reports that people can opt out by requesting a “NO-STUDY” bracelet (call 206-744-7724 or email firstname.lastname@example.org).
The study at Harborview and nine other trauma centers will involve about 1,000 patients, and about 100 of those are at Harborview.